Tag: Cancer: Skin
Teledermoscopy Accurate for Detecting Skin Cancers
TeleTeam detected 11 of 13 skin cancers with clinical photos, dermoscopy alone, with accuracy of 91 percent
Travel Time to Tanning Facilities Negatively Linked to Melanoma Incidence
Six high-risk clusters were identified with respect to county-level melanoma rate
New Set of Risk Factors Can Boost Detection of Suspicious Skin Lesions
C4C risk score achieved sensitivity of 80.46 ± 2.50 percent and specificity of 62.09 ± 1.90 percent, outperforming other models
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
Melanoma incidence decreased for those aged 20 to 29, 30 to 39, 40 to 49 years; decline in melanoma mortality seen for those aged 30 to 59 years
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
Hispanic and non-Hispanic Black sexual minority males and females have higher rates of skin cancer than their heterosexual counterparts
Rural Residents Continue to Have Higher Odds of Skin Cancer
Rural-urban differences magnified by lower income and race
Few Patients With Positive Margins After Basal Cell Excision Have Recurrence
Recurrence developed in more patients who did not receive additional treatment and in fewer receiving nonsurgical treatments
Nonsignificant Survival Benefit Seen for Dabrafenib, Trametinib in Melanoma
Consistent survival benefit seen across several prespecified subgroups, including those with a BRAF V600E mutation
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
Neoadjuvant treatment followed by surgery results in longer event-free survival for resectable, macroscopic stage III melanoma
